Company
Promakhos
Creating transformative medicines for people with inflammatory diseases.
Also known as Promakhos Therapeutics, Inc
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Boston, Massachusetts, United States
- Founded
- 2021
- Legal name
- Promakhos Therapeutics, Inc
Record updated 29 September 2026
About
At Promakhos, we utilize unique insights from patient samples to develop medicines that address the root cause of inflammatory diseases. Instead of blocking the immune system, our medicines aim to restore the natural ability of the body to manage inflammation and heal.
Funding snapshot
- Total raised
- $2.2MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $2.2M2021-03-12
Funding rounds
- Round, 2021
- $2.2M2021-03-12, SEC form D sold, 25 investors